BioSpace News Archive

Lion TCR Pte Ltd, a clinical-stage biotech company specialized in T Cell Receptor (TCR) T cell therapy today announced that it has received clearance from U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) Application for LioCyx-M004, autologous T-cells transfected with mRNA encoding Hepatitis B surface antigen (HBsAg) specific TCR.

Through laser-focused training, delivered simply over a nurse’s own phone or tablet, SMi TrialD, ScienceMedia’s proven education and training solution for decentralized clinical trials, provides powerful training for home healthcare staff that reinforces the highest risk elements of each home visit.

Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities Innate Pharma SA releases its total number of shares outstanding as well as its voting rights as at September 1, 2021

The shareholders of Biovica International AB, reg. no. 556774-6150, are hereby invited to the extra general meeting on Tuesday 12 October 2021.

exocad GmbH, an Align Technology, Inc. company and a leading dental CAD software provider, detailed the company’s achievements over the past year and recent productivity-boosting software innovations at its International Dental Show press event.

RaySearch Laboratories AB announces that the National Cancer Centre Singapore has placed an order for RayStation®* as the treatment planning system for its new proton therapy center currently under construction and scheduled for completion by 2022.

Global health service company Cigna Corporation announced several new leadership roles and positions to drive accelerated growth across its diverse business portfolio.

NeuroVasc Technologies, Inc. announced that the first patient has been treated in a Chinese Pivotal Randomized Controlled Trial to evaluate the safety and efficacy of the ENVI™-SR Mechanical Thrombectomy System, a stent-retriever for the removal of blood clots in patients with acute ischemic stroke due to large vessel occlusion.

MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announces that it has received FDA 510 clearance for the detection of wounds containing clinically significant levels of Pseudomonas aeruginosa for the previously cleared MolecuLight i:X imaging device.

Draupnir Bio announces the establishment of its scientific advisory board comprising global leaders in carbohydrate chemistry, the regulation and genetics of cholesterol metabolism, and in drug development for the treatment of cardiovascular disease.